Please assess the completion status of the following clinical trial:

Trial Title: Nosocomial Infections During Total Prostatic Cystectomies (TPC) With Replacement Enterocystoplasty: Prophylactic Role of Urell®, Cranberry Fruit Juice Extract (Vaccicium Macrocarpon)

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* patient aged \> 18 years old~* patient with bladder cancer and total prostatic cystectomy with replacement enterocystoplasty~* signed informed consent~* patient with healthcare insurance~Exclusion Criteria:~* patient without signed informed consent~* patient deprived of liberty by judicial or administrative decision

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Prophylactic efficacy of Urell® (Type: EXPERIMENTAL): Prophylactic efficacy of Urell® on urinary tract infections in patients with bladder cancer and total prostatic cystectomy with replacement enterocystoplasty

Based on this trial design, predict the completion outcome and termination type (if applicable).